pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Gadobutrol (Primary)
- Indications Multiple sclerosis
- Focus Diagnostic use
- 01 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jun 2019.
- 01 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.
- 13 Jul 2017 Status changed from not yet recruiting to recruiting.